Mohamed Kamal El-Din Aly Fahmy Shaker is the Director of HCC unit in Ain Shams University Hospitals.He is the Vice President of the Egyptian Society of Liver Cancer and President of the committee of treatment of viral hepatitis Cairo branch Health Insurance Organization. He was the Coordinator of the supreme committee of the liver in the Health Insurance Organization (till 2012). He is the Member of the national committee for the control of viral hepatitis and Member of the honorary editorial board of journal of hepatocellular carcinoma.
research interest lie in Infectious diseases, Molecular biology and Hepatitis E.
David H, Van Thiel is a professor of medicine, a former president of the American Association for the study of liver disease and is widely recognized as one of the founding fathers if not, the father of medical liver transplantation worldwide. He attended Pomona College in Clairemont, California, and then entered Medical School at the University of California at Los Angeles graduating with honors in 1967. He has served as the chief of gastroenterology/hepatology at the University of Pittsburgh, Dir. of hepatology at Loyola University Chicago, and Rush University, Chicago. He is currently in private practice of gastroenterology and hepatology with an emphasis on hepatology, which accounts for 80-85% of his practice.
Dr. Hüseyin Sancar Bozkurt has completed his Ph.D. at the age of 24 years from Trakya University and ?nternal Medicine at the age of 30 from Çukurova University. He has completed gastroenterology education at the age of 33 years from Adana Ba?kent University. He had first documented cases about clinical applications and He added hypothesis about microbiota in medical literature. He has published multiple national and international papers.
His research interest includes Pathogenesis of chronic diarrhea, IBS and Neuroimmune modulation.
Emeritus Professor Lynnette Ferguson obtained her DPhil. (Oxon.) from Oxford University in the United Kingdom, working on DNA damage and DNA repair. After her return to New Zealand, she began working as part of the Auckland Cancer Society Research Centre (ACSRC), using mutagenicity testing as a predictor of carcinogenesis. In the year 2000, she became a full Professor and was invited to establish a new department of Nutrition at The University of Auckland. Since that time, she has split her appointment 50/50 between the ACSRC and The University of Auckland. She has investigated the interplay between genes and diet in the development of chronic disease, with particular foci on inflammatory bowel disease and cancer.
Her research interest lies in interplay between genes and diet in the development of chronic disease, with particular foci on inflammatory bowel disease and cancer.
Wasif Saif, MD, is an internationally recognized expert in gastrointestinal (GI) cancers, experimental therapeutics, and pharmacogenetics. He serves as Professor of Medicine in the Division of Hematology/Oncology at Tufts University School of Medicine as well as Director of the GI Oncology Program and Program Leader for Experimental Therapeutics at Tufts Medical Center. Previous appointments include Director of the GI Cancer Disease Program at Yale Cancer Center, Director of the GI Cancers Section and Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons, and Medical Director of the Pancreas Center at New York-Presbyterian Hospital.
His research interests include the study of pharmacokinetics and pharmacodynamics in drug development for GI malignancies; biomarker discovery and analysis; development of fluoropyrimidines and toxicity management using pharmacogenetics; and the epidemiology of GI cancers and health outcomes.
Dr. Maisam Akroush is a Gastroenterologist and Hepatologist. She received her medical degree in School of Medicine at University of Jordan in 1995. She is a Board Certified by Jordan Board of Internal Medicine. She is now 13 years practicing as Gastroenterologist. She is a Consultant Internist/Gastroenterologist and Hepatologist at Prince Hamzeh Hospital in Jordan.
Her research interest lies in Gastroenterology and Hepatology.
Dr. Zerem is Professor of Internal Medicine at the University of Tuzla School of Medicine and Director for research and education at the University Clinical Center Tuzla. He received his medical degree from the University of Belgrade, Serbia (1977) and became Specialist of Internal Medicine (1983) and Gastroenterology (1988). He received his Master of Science degree in 1991 and his PhD degree in 1994, both from the University of Tuzla, Bosnia. His research interests focus on the diagnosis and treatment of acute pancreatitis, the application of interventional ultrasound in gastroenterology and hepatology, acid-related disorders, and viral hepatitis. Dr. Zerem has authored more than 100 manuscripts, reviews and book chapters. He is reviewer for Dr. Zerem is Professor of Internal Medicine at the University of Tuzla School of Medicine and Director for research and education at the University Clinical Center Tuzla. He received his medical degree from the University of Belgrade, Serbia (1977) and became Specialist of Internal Medicine (1983) and Gastroenterology (1988). He received his Master of Science degree in 1991 and his PhD degree in 1994, both from the University of Tuzla, Bosnia.
Dr. Zerem research interests focus on the diagnosis and treatment of acute pancreatitis, the application of interventional ultrasound in gastroenterology and hepatology, acid-related disorders, and viral hepatitis.
Fatma Amer is the past head of Medical Microbiology and Immunology, Zagazig Faculty of Medicne, Egypt and the past president of the Arab Alliance for the Prudent Use of Antimicrobials. Currently she is emeritus professor in the same university, the president of Hepatitis Working Group/International Society of Chemotherapy and Infection and is a board member of the International Society for Infectious Diseases. She supervised and evaluated many MSc and PhD theses, and is a reviewer of manuscripts submitted for journals, conferences and international awards. She published numerous articles in reputed national and international journals. She was the first to introduce automated Microbiology Service in her university. She participated in the establishment of the Molecular Biology Unit and introduced an MSc degree in Infection Control at her faculty. She developed two volumes of Infection Control books; the first of their kind in Egypt. She participated in conferences all over the world as organizer, chairperson and speaker.
Her research interest lie in Infectious diseases, Molecular biology and Hepatitis E.
Susan graduated with a B.Sc from NUI Maynooth in Biology and Mathematics and a research PhD in host-miocrobe interactions. She was awarded a Marie Curie Fellowship to examine cis and trans acting factors affecting mRNA synthesis and microbial gene expression at the Ecole Normal Superieure, Paris which included a stint at the Max Planck Institute, Berlin. Before returning to UCC, Susan was a postdoctoral scientist at Trinity College Dublin and the Univerity of Bath, UK.Susan’s main interest is in microbial genetic and biochemical systems that alter eukaryotic host signaling. Susan is currently a Lecturer in the School of Biochemistry and Cell Biology and a PI in the APC Research Theme 4 Host- Microbe Dialogue.
Her research interest lies in microbial genetic and biochemical systems that alter eukaryotic host signaling.
Dr. Larry Good has been a practicing gastroenterologist since 1978. Dr. Good graduated Colgate University Magna Cum Laude in 1969 and received his M.D. with Alpha Omega Alpha status from the Medical University of South Carolina in Charleston, SC in 1973. Dr. Good served a medical residency from 1973-76 and was Chief Medical Resident in 1976. He was fellowship trained in gastroenterology from 1976-78. Dr. Good has served as the Director of Liver Diseases at Nassau County Medical Center and was for many years Chief, Division of Gastroenterology, Department of Medicine at South Nassau Communities Hospital. Dr. Good is an assistant clinical professor of medicine at SUNY Stony Brook. He has given hundreds of lectures in his field and has authored numerous papers and abstracts. Recently, Dr. Good presented the ACG Theater lecture at the American College of Gastroenterology annual meeting in Chicago, Illinois in October, 2014. Dr. Good was Chief Medical Officer at Ritter Pharmaceuticals in Los Angeles, California, where he expanded his research interest in the intestinal microbiome. Dr. Good’s current clinical research activities involve the microbiome, inflammatory bowel disease, irritable bowel syndrome and the application of orally administered gamma globulin to patients with acute and chronic gastro-intestinal disorders. Dr. Good founded Good Pharmaceutical Development Co., LLC, in 2014. He is their CEO and is developing a topical product for treating neuropathic pain. Dr. Good was recently appointed CEO of Compassionate Care Center of New York, a company founded to provide medical marijuana product safely and affordably to residents of New York State adhering to the evolving NYS regulations and producing a pharmaceutical grade treatment option for specific diagnosis designated use. Dr. Good was appointed as an editor of BMC Gastroenterology, a prestigious on line peer-reviewed medical journal. He is a member of the Speakers Bureau for Entera Health, Abbvie and Cubist Pharmaceuticals. Dr. Good currently receives research grants from Entera Health and Medicus Biosciences. Dr. Good is the former C.E.O. of Compassionate Care Center of NY and has had a long interest in research application of the physiology of natural molecules to multiple disease states. Currently, Dr. Good is the C.E.O. of New Century Health Alliance, L.L.C., a Continuing Medical Education Company certified to provide 6.25 AMA PRA credits for education in the area of medical marijuana treatment. In May, 2016, Dr. Good was named to the Steering Committee for Medical Marijuana Research and Education Division, Department of Integrated Medicine at Thomas Jefferson Medical University in Philadelphia. He has just completed a manuscript soon to be published on the treatment of Crohn’s Disease and Ulcerative Colitis with medical marijuana pharmaceuticals.
Prof. Dr. Amin El-Gohary completed his MBBCh in 1972 and his Diploma in General Surgery in 1975 at Cairo University, Egypt. He became a fellow of The Royal College of Surgeons in UK: Edinburgh in 1979, London in 1980, and Glasgow in 1997. Prof. Dr. Amin worked initially in Egypt, then moved to Kuwait, then to UK, before coming to UAE in 1983. In the same year, he became the Chief and Head of the Department of Pediatric Surgery of a large government hospital. Additionally, he held post as a Medical Director for the same hospital starting 1989. He was appointed as Chief Disaster Officer during Gulf War in 1991. He also held post as the Clinical Dean of Gulf Medical College, Ajman for 3 years. Prof. Dr. Amin is well known in Abu Dhabi for his extensive interest and involvement in scientific activities. He is the President of the Pediatric Surgical Association of UAE. He was awarded the Shield of the College of Pakistan in 1996 and the Medal of International Recognition in pediatric urology from the Russian Association of Andrology in 2010. He was given a Silver Medal from the Royal College of Surgeons – Ireland in 1978 and an Honorary Fellowship from the Royal College of Surgeons – Glasgow in 1997. In 2001, he became a Visiting Professor at Munster University, Germany. Prof. Dr. Amin is a member of several associations in pediatric surgery: Executive Member of the International Society of Intersex and Hypospadias Disorder (ISHID), British Association of Pediatric Surgery, Egyptian Association of Pediatric Surgeons, Asian Association of Pediatric Surgeons, and Pan African Association of Pediatric Surgery. He is also the founder and member of the Arab Association of Pediatric Surgeons. Prof. Dr. Amin has an intensive academic and teaching experience, has written several publications in distinguished medical journals, and has made several poster and paper presentations in national and international conferences. Currently, he is an external examiner for the Royal College of Surgeons
Amany Sholkamy had completed her PhD in 1997 from Cairo University, Egypt. She is professor (full) of medicine and hepatology in Faculty of Medicine Cairo university since 2008. Amany is a member of the scientific committee of the Supreme Council of Egyptian Universities since 2013. Amany was the founder and clinical supervisor of the liver ICU in the French Kasr AlAiny H Cairo university in 2005 till now. She is working also as senior liver transplant consultant in Manial specialized H Cairo university since 2004, and senior sonologist in Internal Medicine H Cairo university. Amany had supervised many master and MD researches through her work in the faculty. She has many national and international publications in the field of hepatology, hepatic emergencies, and liver transplantation. Amany had finished a Master degree of organ procurement and transplantation management from DTI/Barcelona university Spain 2018.
Laila Eissa, Egyptian science educator. Doctor of Philosophy in Biochemistry, Moscow Institute Fine Chemical Technology, 1994. MsD, Moscow Institute Fine Chemical Technology, 1989. Graduate, Mansoura University, 1986.Achievements include research in the role of nitric oxide in the treatment of bilharziasis; research in the role of Spirulina platensis in liver disease & aging. Member of Mansoura University Social Club, Egyptian Pharmaceutical Society.